Jafron Biomedical Co.,Ltd.’s Net Profit Dropped 63.1% in First Half of 2023

Jafron Biomedical Co.,Ltd. (健帆生物科技集团股份有限公司) (300529.SZ) reported a net profit of 275.2 million yuan in the first half of 2023, down 63.1% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, down 34.9% year-on-year.

At the end of the reporting period, it had 5.6 billion yuan in total assets and 2.4 billion yuan in total liabilities, with a liability-to-asset ratio of 42.3%.